SCHEMBL3401928

SCHEMBL3401928

CC(C)(C=O)Cc1c[nH]c2ncc(-c3ccnc(N4CCC(F)(F)C4)c3)nc12

nearest known ligand 0.34

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAP3K12 Q12852 7/20 0.34
LRRK2 Q5S007 2/20 0.33
JAK2 O60674 1/20 0.33
MAPK1 P28482 3/20 0.33
KLKB1 P03952 1/20 0.33
KLK1 P06870 1/20 0.33
CNR2 P34972 3/20 0.33
PIM1 P11309 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
JAK3 P52333 1/20 0.32
CACNA1H O95180 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3401949 0.84 MAPK1 (0.35) MAPK1JAK3
SCHEMBL3399528 0.84 LRRK2 (0.39) LRRK2MAPK1KLKB1KLK1PIM1
SCHEMBL3397988 0.84 LRRK2 (0.39) LRRK2MAPK1KLKB1KLK1PIM1
SCHEMBL3399555 0.83 ITGB2 (0.39) LRRK2MAPK1KLKB1KLK1PIM1
SCHEMBL3398822 0.82 ITGB2 (0.39) PIM1PIM2JAK3
SCHEMBL3399086 0.81 JAK3 (0.36) JAK2MAPK1JAK3
SCHEMBL1890101 0.80 JAK3 (0.44) MAP3K12JAK2JAK3
SCHEMBL3397858 0.80 HRH4 (0.42) LRRK2KLKB1KLK1JAK3
SCHEMBL3401593 0.79 SYK (0.36) MAPK1KLKB1KLK1JAK3
SCHEMBL3396245 0.78 MAPK1 (0.36) LRRK2MAPK1CNR2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247592-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-10 EP claimed
WO-2009106442-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO claimed
EP-2247592-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-11-10 EP disclosed
WO-2009106442-A1 PYRROLOPYRAZINE KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-09-03 WO disclosed